The Default Mode Network: Anatomy, Function, and Therapeutic Modulation

Back to: Psychedelics, Entheogens, and Consciousness Expansion

The Default Mode Network 

Anatomy, Function, and Therapeutic Modulation

 

There’s a particular kind of silence that isn’t silent at all. You sit down, close your eyes, put the phone away, stop working, stop talking, and within about ninety seconds the story starts. Not a story about what’s out there. A story about you. What you said in that meeting five years ago. What you should have said instead. Who you are. Who you’re becoming. Where you fell short. Where you’re headed next. It runs whether you invited it or not, and for most of us it runs nearly all day, humming quietly underneath everything else we do.

For a long stretch of my life I assumed that voice was simply me. My thinking, doing what thinking does. It took years of sitting still, first in formal meditation and later long stretches of Colorado trail where there was nothing left to do but walk and breathe, before I understood something important: the narrator and the self are not the same thing. The narrator is a process. And that process has an address in the brain.

Neuroscientists call it the Default Mode Network, or DMN. Understanding what it is, where it lives, and what happens when it goes quiet gives us one of the clearest bridges available right now between hard neuroscience and the contemplative traditions that have been mapping this same territory, in very different language, for thousands of years. It’s also central to understanding why psilocybin and other entheogens produce the effects they do, which is where this module is ultimately headed.

The DMN is a large scale network of interconnected brain regions that becomes more active, not less, when you stop focusing on the outside world. Turn your attention outward toward a task, a conversation, a problem to solve, and this network quiets down. Let your attention drift inward, and it lights back up. Researchers sometimes call it the brain’s “cognitive autopilot,” because it’s the system running the show whenever nothing else is asking to run it.

The idea has an older pedigree than most people realize. In 1929, Hans Berger, the physician who invented the electroencephalogram, proposed that the brain stays constantly busy even at rest, a claim that took most of a century to fully vindicate. It wasn’t until the 1990s, once PET scans became sophisticated enough to compare brain activity during rest against activity during demanding tasks, that researchers noticed something odd. A specific set of regions kept dialing back their activity every time a subject was given something to do. For a while these areas were simply labeled “deactivated,” a kind of negative space in the data. It took time for the pattern to be recognized as something positive in its own right: a cohesive network that was busiest exactly when the mind turned inward.

Neuroscientist Marcus Raichle gave the network its name in 2001, calling it the “default mode,” the state the brain returns to by default when no external demand is pulling it elsewhere. You’ll also see it called the “task-negative network,” though that label is a bit of a misnomer since the DMN is quite active during plenty of internal, goal-directed tasks like remembering, imagining, and moral reasoning. For that reason, many researchers today prefer the more anatomical term medial frontoparietal network, or M-FPN. In this module I’ll stick with DMN, since it’s still the term you’ll encounter most often in the clinical and psychedelic research literature.

A Network Among Networks

The brain doesn’t run on one system at a time. It maintains a dynamic, shifting balance among several large-scale networks, and understanding the DMN means understanding who it’s in conversation with.

The Task-Positive Network (TPN), also called the dorsal attention network, activates during externally focused, demanding work. It and the DMN behave like a seesaw. When one goes up, the other typically goes down, an anti-correlation that shows up reliably across brain-imaging studies.

The Salience Network uses the insular cortex to flag what matters right now, alerting you to important stimuli or threats in the environment and helping decide which network, the DMN or the TPN, should take the wheel.

The Executive Control Network manages decision-making, directs attention deliberately, and keeps a working eye on the external environment once something has been flagged as worth engaging.

You can think of these three systems as a kind of internal governance structure. The salience network is the sentry, the executive network is the decision-maker, and the DMN and TPN are the two very different modes of engagement, inward and outward, between which attention constantly shifts. Nothing about this is pathological. It’s simply how a healthy mind manages the world. Trouble tends to begin when the balance gets stuck, which we’ll return to shortly.

The DMN isn’t a single structure. It’s a coordinated system of hubs and subsystems, each contributing a distinct piece to the ongoing construction of your inner life.

The Primary Hubs

Region	Core Function
Posterior Cingulate Cortex (PCC) & Precuneus	The network’s central core. Integrates attention with memory and perception and contributes to spatial navigation and overall arousal.
Medial Prefrontal Cortex (mPFC)	Manages self-processing: personal information, future goals, and internally valued rewards.
Angular Gyrus	Connects perception, spatial cognition, and action, and assists in recalling episodic memories.

Two Specialized Subsystems

Beyond these core hubs, the DMN organizes into two subsystems that handle different dimensions of inner experience.

The dorsal medial subsystem handles thinking about other people. It includes the dorsal medial prefrontal cortex (socially directed thought), the temporoparietal junction (which supports theory of mind, our capacity to infer what someone else is thinking or feeling), and the lateral temporal cortex (social and conceptual knowledge).

The medial temporal subsystem handles memory and simulation. It includes the hippocampus (forming new memories), the parahippocampus (recognizing scenes and places), and the retrosplenial cortex (spatial navigation).

Put simply, one branch of this network is built to model other minds, and the other is built to model time, the past you remember and the future you imagine. Both branches feed the same central hub, the PCC, which is part of why the sense of self feels so seamless even though it’s assembled from genuinely separate ingredients.

It’s worth pausing here, because this is the part most people skip past without letting it land. The DMN isn’t just a brain region that happens to be active during daydreaming. It is the primary architect of your inner life, the system responsible for constructing the very sense that there is a “you” having this experience at all.

Constructing the self. The DMN processes autobiographical facts, self-referential traits, and reflections on your own emotional state. This is the machinery behind the felt sense of being a continuous person moving through time.

Social cognition. It enables theory of mind, the ability to infer what someone else is thinking, feeling, or intending, and it supports moral reasoning and social evaluation more broadly.

Mental time travel. The network is essential to both remembering the past through episodic memory and simulating the future, imagining scenarios that haven’t happened yet.

Narrative comprehension. Brain-imaging studies show that the DMN activity of different people synchronizes when they listen to or read the same story, suggesting this network is doing the deep conceptual work of comprehension itself, not just passive listening.

Aesthetic perception. The DMN activates in response to moving art, architecture, and landscapes, linking the experience of beauty directly to personal identity. Something in you recognizes itself in what moves you.

This is worth sitting with. The same network that lets you recall your childhood, imagine your future, understand another person’s pain, and be moved by a mountain vista is the network that also generates the ongoing narrative of who you are. Aldous Huxley, borrowing a phrase from the philosopher C. D. Broad, once described the brain as a “reducing valve,” a system built to filter an otherwise overwhelming reality down to the narrow, survival-useful trickle we call ordinary consciousness. The DMN looks very much like a physical mechanism for exactly that kind of filtering, and this is a thread we’ll pick up again in the module on filter theory. For now, the point is simply this: the self you experience as solid and continuous is, in real and measurable ways, a construction. And constructions can be examined, and sometimes, gently, rebuilt.

A well-functioning DMN moves fluidly, engaging when you need to reflect, remember, or connect with another person, and stepping back when the outside world needs your full attention. Disruptions to that fluidity, whether the network becomes too dominant, too quiet, or poorly coordinated with its neighbors, show up across a range of mental health and neurodegenerative conditions.

Major Depressive Disorder (MDD). Hyperconnectivity in the DMN is associated with compulsive rumination, the replaying of regrets, failures, and shame on a loop. The network becomes dominant over the others, keeping a person, in the plainest possible language, stuck in their own head.

Alzheimer’s Disease. Amyloid-beta plaques often accumulate in DMN hubs before symptoms ever appear. The network’s continuous high metabolic activity may itself contribute to this buildup over time, which eventually disrupts memory formation.

Autism Spectrum Disorder. Reduced connectivity between the mPFC and PCC is frequently observed and correlates with challenges in social interaction and communication.

ADHD. Marked by a reduced anti-correlation between the DMN and the task-positive network, often attributed to a lag in brain maturation, which helps explain why sustained external focus can be so difficult to summon on demand.

PTSD and Trauma. Severe PTSD is linked to lower connectivity within the DMN and reduced activation in the posterior cingulate gyrus, a reminder that dysregulation runs in more than one direction. Sometimes the story loops too tightly. Sometimes it fractures.

None of this is meant to reduce a person’s suffering to a wiring diagram. But there is something quietly hopeful in it too. If a network can become dysregulated, it can also, with the right conditions, be brought back into balance. That’s the subject of the next section.

Several distinct interventions have been shown to calm, desynchronize, or otherwise “reset” an overactive DMN. They arrive from very different traditions, contemplative practice, direct encounters with awe, and psychedelic medicine, yet they appear to be converging on the same underlying target.

Meditation and Mindfulness

Meditation trains attentional control, and over time that training dials down baseline inward-focused activity. Long-term practitioners show significantly lower baseline DMN activity and reduced functional connectivity compared to beginners, which is part of why experienced meditators are more successful at curtailing mind-wandering once they notice it starting. The practice doesn’t just change behavior in the moment. Consistent practice produces measurable structural changes in nodes like the PCC and precuneus, the same hubs at the center of the network we’ve been discussing.

Style matters more than people expect. Mindfulness and other focused-attention styles of meditation quiet the DMN. But nondirective styles, such as Transcendental Meditation or Acem Meditation, can activate the network rather than suppress it, likely because these approaches allow thoughts, memories, and associations to surface and be processed rather than held at bay. Neither approach is wrong. They’re doing different work, and it’s worth knowing which one you’re practicing and why.

The Awe Effect

Experiences of awe, standing before vast landscapes, mountain vistas, the ocean at night, shift attention sharply outward. That outward pull naturally interrupts the DMN’s self-referential churn, offering real relief from what I’d call stewing in your own troubles. I’ve felt this directly more times than I can count, standing at a Colorado overlook after a long climb with nothing left in me to keep narrating. The mental chatter doesn’t argue its way into silence. It just isn’t needed anymore. Interestingly, the research suggests a distinction worth knowing: awe specifically quiets the network, while general environmental beauty, pleasant but not awe-inducing, tends to activate it instead. Beauty invites reflection. Awe interrupts it.

Psilocybin and Neural Desynchronization

Psilocybin, once metabolized in the body to psilocin, acts primarily as an agonist at serotonin 2A (5-HT2A) receptors, which are especially dense in the DMN’s cortical hubs, particularly the PCC and mPFC. The result is a rapid and profound desynchronization of the network. Blood flow to these primary hubs drops, and the rigid, over-learned organization of the network temporarily comes apart. Entrenched negative self-narratives, the loops that keep replaying the same regret or the same fear, lose their usual grip because the network carrying them for a few hours is no longer running its familiar groove.

Researchers describe this as a kind of neuroplastic “reset,” a window in which the cognitive autopilot of rumination gets switched off long enough for a person to step outside it and, often for the first time in years, see the story rather than simply live inside it. What happens next, how that window gets used, is where integration work becomes essential, and it’s the subject of its own module later in this course.

Given how central DMN regulation is to conditions like depression, it’s worth putting the two leading approaches, conventional antidepressants and psilocybin-assisted therapy, side by side. Research from institutions including Johns Hopkins and Imperial College London suggests these represent genuinely different treatment models; not just different drugs aimed at the same target.

What the Trials Actually Show

In a landmark Johns Hopkins trial of psilocybin for cancer-related existential distress, roughly two thirds of participants, about 67 percent, described their psilocybin session as among the five most personally meaningful experiences of their entire lives. At six-month follow-up, around 80 percent maintained clinically significant reductions in depression and anxiety, and about 83 percent reported enhanced well-being or life satisfaction. It’s worth being precise about these two figures rather than blending them into one, because they’re measuring different things: how meaningful the experience felt, and how durable the clinical benefit turned out to be. Both numbers are striking. Neither should be mistaken for the other.

In a small pilot study of long-term smokers, psilocybin-assisted treatment showed real promise for addiction as well. Sixty percent of participants remained biologically confirmed abstinent at roughly two and a half years of follow-up, a result that compares favorably to the well under one-third abstinence typically seen with conventional cessation treatments at just twelve months. The study’s size was modest, only fifteen participants, so it should be read as a genuinely promising signal rather than a settled conclusion. Larger trials are underway to see whether the effect holds at scale.

The most direct comparison comes from a head-to-head trial against escitalopram, a standard SSRI, published in the New England Journal of Medicine. On the primary measure of depression severity at six weeks, psilocybin did not show a statistically significant advantage. But on several secondary measures it performed meaningfully better, including a remission rate roughly twice as high, 57 percent versus 28 percent. The trial’s own researchers were careful to note that these secondary comparisons weren’t adjusted for multiple comparisons, so no firm conclusions can yet be drawn from them alone. Further trials are needed, and are underway, before psilocybin can be called clinically superior. What can already be said is that it performed at least as well as a leading conventional antidepressant, from a single course of treatment rather than an open-ended daily prescription.

Side by Side

Feature	Conventional SSRIs (e.g., Escitalopram)	Psilocybin-Assisted Therapy
Dosing Structure	Required daily, indefinitely.	One or two guided sessions.
Durability	Effects fade quickly if stopped.	Benefits can persist for up to a year.
Clinical Efficacy	Standard tool; requires ongoing management.	Remission rates roughly twice as high in some trials.
Patient Experience	Routine medication.	Often ranked among the most personally meaningful life experiences.
Biological Effect	Daily modulation of serotonin signaling.	Rapid DMN desynchronization and reduced amygdala reactivity.

Taken together, this represents something closer to a paradigm shift than an incremental improvement: a move away from the daily-management model that has defined psychiatric medication for decades, toward a model built around a small number of carefully guided experiences aimed at genuine, lasting change in how the mind relates to itself.

If you’ve been doing your own inner work for a while, meditation, therapy, contemplative study, journaling, you may already have suspected that the voice in your head and the self it claims to describe aren’t quite the same thing. That intuition, it turns out, has a home in the physical architecture of the brain. The Default Mode Network is real, it’s measurable, and it’s remarkably consistent in what it does: it builds the sense of self, narrates the past and future, connects you to other minds, and lets you recognize beauty as something that belongs to you.

It’s also not the whole of you. That’s the part worth carrying forward as we move into the next module, on filter theory, and later into the direct territory of the entheogenic experience itself. When the narrator goes quiet, whether through years of disciplined practice, a single unforgettable encounter with awe, or the careful, guided use of a substance like psilocybin, something doesn’t disappear. Something becomes available again, underneath the story, that was there all along.

The Great Work is here. The Great Work is now. And the Great Work is you. – James Sageman

 

Berger, H. (1929), early EEG observations of continuous brain activity at rest.

Raichle, M. E., et al. (2001). “A default mode of brain function.” Proceedings of the National Academy of Sciences.

Xu, J., et al. (2014). “Nondirective meditation activates default mode network and areas associated with memory retrieval and emotional processing.” Frontiers in Human Neuroscience.

Griffiths, R. R., et al. (2016). “Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer.” Journal of Psychopharmacology. (Johns Hopkins)

Johnson, M. W., et al. (2017). “Long-term follow-up of psilocybin-facilitated smoking cessation.” The American Journal on Addictions.

Carhart-Harris, R., et al. (2021). “Trial of Psilocybin versus Escitalopram for Depression.” New England Journal of Medicine.